Back to Search Start Over

S94. PREDICTION OF CANNABIS RELAPSE IN CLINICAL HIGH-RISK INDIVIDUALS AND RECENT ONSET PSYCHOSIS - PRELIMINARY RESULTS FROM THE PRONIA STUDY

Authors :
Penzel, N
Sanfelici, R
Betz, L
Antonucci, L
Falkai, P
Upthegrove, R
Bertolino, A
Borgwardt, S
Brambilla, P
Lencer, R
Meisenzahl, E
Ruhrmann, S
Salokangas, RKR
Pantelis, C
Schultze-Lutter, F
Wood, S
Koutsouleris, N
Kambeitz, J
Penzel, N
Sanfelici, R
Betz, L
Antonucci, L
Falkai, P
Upthegrove, R
Bertolino, A
Borgwardt, S
Brambilla, P
Lencer, R
Meisenzahl, E
Ruhrmann, S
Salokangas, RKR
Pantelis, C
Schultze-Lutter, F
Wood, S
Koutsouleris, N
Kambeitz, J
Publication Year :
2020

Abstract

Background Evidence exists that cannabis consumption is associated with the development of psychosis. Further, continued cannabis use in individuals with recent onset psychosis (ROP) increases the risk for rehospitalization, high symptom severity and low general functioning. Clear inter-individual differences in the vulnerability to the harmful effects of the drug have been pointed out. These findings emphasize the importance of investigating the inter-individual variability in the role of cannabis use in ROP and to understand how cannabis use relates to subclinical conditions that predate the full-blown disease in clinical high-risk (CHR). Specific symptoms have been linked with continued cannabis consume, still research is lacking on how different factors contribute together to an elevated risk of cannabis relapse. Multivariate techniques have the capacity to extract complex patterns from high dimensional data and apply generalized rules to unseen cases. The aim of the study is therefore to assess the predictability of cannabis relapse in ROP and CHR by applying machine learning to clinical and environmental data. Methods All participants were recruited within the multi-site, longitudinal PRONIA study (www.pronia.eu). 112 individuals (58 ROP and 54 CHR) from 8 different European research centres reported lifetime cannabis consume at baseline and were abstinent for at least 4 weeks. We defined cannabis relapse as any cannabis consume between baseline and 9 months follow-up reported by the individual. To predict cannabis relapse, we trained a random forest algorithm implemented in the mlr package, R version 3.5.2. on 183 baseline variables including clinical symptoms, general functioning, demographics and consume patterns within a repeated-nested cross-validation framework. The data underwent pre-processing through pruning of non-informative variables and median-imputation for missing values. The number of trees was set to 500, while the number of nodes, sa

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1315662276
Document Type :
Electronic Resource